Industry

DUBLIN–(BUSINESS WIRE)–The “Cancer Diagnostic Collaboration and Licensing Deals 2018-2025” report has been added to ResearchAndMarkets.com’s offering. This report contains a comprehensive listing of 724 cancer diagnostic deals announced since 2018 including financial terms where available including links to online deal records of actual cancer diagnostic partnering deals as disclosed by the deal parties. In addition, … [Read more…]

— First Patients Dosed with BCMA T-cell engager (cizutamig) and CD20 T-cell engager (CND261) — Clinical Studies in IgA Nephropathy, Myasthenia Gravis, Rheumatoid Arthritis, Systemic Lupus Erythemotosus and Systemic Sclerosis are Underway — CMC Established to Facilitate Global Clinical Trials — China Operations Established for Early Clinical Development SAN DIEGO–(BUSINESS WIRE)–Candid Therapeutics, Inc. (“Candid”), a … [Read more…]

5th Annual 5K-10K Run/Walk & Kids Fun Run Honoring Healthcare Heroes, Featuring Special Guests Bastian Michel, Former Santa Clara Valley Medical Center Patient, and Susan Benton, RN Assistant Nurse Manager, Pediatric ICU SAN JOSE, Calif.–(BUSINESS WIRE)–The Independence Day holiday kicks off early with the 5th Annual Bloom Energy and Tarana Wireless Stars and Strides Run, … [Read more…]

ATLANTA–(BUSINESS WIRE)–Mirion, a global leader in radiation safety, science, and medicine, announced today that its Mirion Medical group will showcase its portfolio of solutions designed to enable the radiopharma and theranostic fields at the 2025 Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting, June 21-24, in New Orleans, Louisiana. New products from Capintec … [Read more…]

Marketing Authorization application of Xervyteg® (MaaT013) in acute graft-versus-host-disease submitted to the European Medicines Agency (EMA) in June 2025 MAA could be expected in H2 2026 allowing, if approved, for commercialization of Xervyteg® in Europe As part of a strategic focus on Xervyteg®’s registration activities in Europe, the Phase 3 dedicated trial launch in the … [Read more…]

NEW YORK–(BUSINESS WIRE)–Surgimate, a leading provider of surgical coordination and scheduling software in the U.S., today announced the appointment of Jessica Cook to the newly created position of Chief Revenue Officer. As CRO, Cook will oversee all sales and marketing efforts across Surgimate’s business lines, including surgical scheduling, medical device coordination and patient access. She … [Read more…]

The new suite of products unlocks greater access to Hi-C metagenomic research, accelerating discovery from complex microbial communities in human and environmental research applications SEATTLE–(BUSINESS WIRE)–Phase Genomics, Inc., a leader in genomic technology development, today announced the launch of its new ProxiMeta Starter and Elite Bundles, comprehensive product offerings that make genome- and mobilome-resolved metagenomics … [Read more…]

PARMA, Italy–(BUSINESS WIRE)–#ChiesiGlobalRareDiseases–Chiesi Global Rare Diseases, a business unit of the Chiesi Group established to deliver innovative solutions for people living with rare diseases, today announced the recipients of its “Find For Rare” research grant program. The independently assessed, expert-led research grant initiative aims to improve patient care and management by recognising innovative research in … [Read more…]

New office located in the heart of Uxbridge underscores Celltrion’s long-term business commitment in the UK LONDON–(BUSINESS WIRE)–Celltrion UK has officially opened its new UK headquarters at the Charter Building in Uxbridge, UK, reinforcing the company’s dedication to long-term growth and partnership in the UK market. The opening ceremony was attended by Hyoung-Ki Kim, CEO … [Read more…]

Gilead prices potential ‘game changer for HIV prevention’ at an eyepopping $28K per year LOS ANGELES–(BUSINESS WIRE)–The U.S. Food and Drug Administration approved use of Gilead’s HIV treatment medication, lenacapavir, for use to prevent HIV infection earlier today, an action which was followed by news that Gilead intends to price the HIV prevention medication at … [Read more…]